BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26174772)

  • 1. Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1.
    Michelhaugh SK; Guastella AR; Varadarajan K; Klinger NV; Parajuli P; Ahmad A; Sethi S; Aboukameel A; Kiousis S; Zitron IM; Ebrahim SA; Polin LA; Sarkar FH; Bollig-Fischer A; Mittal S
    J Transl Med; 2015 Jul; 13():227. PubMed ID: 26174772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the cell lines used in meningioma research.
    Ragel BT; Couldwell WT; Gillespie DL; Wendland MM; Whang K; Jensen RL
    Surg Neurol; 2008 Sep; 70(3):295-307; discussion 307. PubMed ID: 18261772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus.
    Nigim F; Esaki S; Hood M; Lelic N; James MF; Ramesh V; Stemmer-Rachamimov A; Cahill DP; Brastianos PK; Rabkin SD; Martuza RL; Wakimoto H
    Neuro Oncol; 2016 Sep; 18(9):1278-87. PubMed ID: 26951380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth.
    McCutcheon IE; Friend KE; Gerdes TM; Zhang BM; Wildrick DM; Fuller GN
    J Neurosurg; 2000 Feb; 92(2):306-14. PubMed ID: 10659019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth.
    Das A; Alshareef M; Henderson F; Martinez Santos JL; Vandergrift WA; Lindhorst SM; Varma AK; Infinger L; Patel SJ; Cachia D
    Clin Transl Oncol; 2020 Jul; 22(7):1138-1145. PubMed ID: 31732915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings.
    Al-Mefty O; Kadri PA; Pravdenkova S; Sawyer JR; Stangeby C; Husain M
    J Neurosurg; 2004 Aug; 101(2):210-8. PubMed ID: 15309910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas.
    Pravdenkova S; Al-Mefty O; Sawyer J; Husain M
    J Neurosurg; 2006 Aug; 105(2):163-73. PubMed ID: 17219818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of meningiomas.
    Solomon DA; Pekmezci M
    Handb Clin Neurol; 2020; 169():87-99. PubMed ID: 32553300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTORC1 inhibitors suppress meningioma growth in mouse models.
    Pachow D; Andrae N; Kliese N; Angenstein F; Stork O; Wilisch-Neumann A; Kirches E; Mawrin C
    Clin Cancer Res; 2013 Mar; 19(5):1180-9. PubMed ID: 23406776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth.
    Burns SS; Akhmametyeva EM; Oblinger JL; Bush ML; Huang J; Senner V; Chen CS; Jacob A; Welling DB; Chang LS
    Cancer Res; 2013 Jan; 73(2):792-803. PubMed ID: 23151902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of an in vivo meningioma model with human telomerase reverse transcriptase.
    Cargioli TG; Ugur HC; Ramakrishna N; Chan J; Black PM; Carroll RS
    Neurosurgery; 2007 Apr; 60(4):750-9; discussion 759-60. PubMed ID: 17415213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation.
    Peyre M; Stemmer-Rachamimov A; Clermont-Taranchon E; Quentin S; El-Taraya N; Walczak C; Volk A; Niwa-Kawakita M; Karboul N; Giovannini M; Kalamarides M
    Oncogene; 2013 Sep; 32(36):4264-72. PubMed ID: 23045274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of oncogenetic trees mixtures as a biostatistical model of the clonal cytogenetic evolution of meningiomas.
    Ketter R; Urbschat S; Henn W; Feiden W; Beerenwinkel N; Lengauer T; Steudel WI; Zang KD; Rahnenführer J
    Int J Cancer; 2007 Oct; 121(7):1473-80. PubMed ID: 17557299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaplastic and meningothelial meningiomas in a single tumor: A "dedifferentiated meningioma"?
    Shintaku M; Adachi Y; Arai A; Koyama J
    Neuropathology; 2016 Dec; 36(6):584-590. PubMed ID: 27374325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: Adjuncts to histopathological grading and predictors of aggressive behavior.
    Kumar S; Kakkar A; Suri V; Kumar A; Bhagat U; Sharma MC; Singh M; Suri A; Sarkar C
    Neurol India; 2014; 62(4):376-82. PubMed ID: 25237942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genetic strategy to overcome the senescence of primary meningioma cell cultures.
    Baia GS; Slocum AL; Hyer JD; Misra A; Sehati N; VandenBerg SR; Feuerstein BG; Deen DF; McDermott MW; Lal A
    J Neurooncol; 2006 Jun; 78(2):113-21. PubMed ID: 16554968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
    Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
    Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes.
    Cutz JC; Guan J; Bayani J; Yoshimoto M; Xue H; Sutcliffe M; English J; Flint J; LeRiche J; Yee J; Squire JA; Gout PW; Lam S; Wang YZ
    Clin Cancer Res; 2006 Jul; 12(13):4043-54. PubMed ID: 16818704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.